Literature DB >> 6415179

Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types.

S P Singh, N K Mehra, H B Dingley, J N Pande, M C Vaidya.   

Abstract

To demonstrate human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis, 25 multiple-case families were tissue typed for class I and class II HLA specificities. Eight non-HLA genetic markers were also examined for any indication of other genetic factors that might influence the Mycobacterium tuberculosis infection. Observations on estimated HLA haplotype segregation in the sibs suggest that 84% of the affected sibs shared significantly more often than expected a common haplotype with each other than the normal unaffected sibs (P less than 0.001). Also, there was a skewed transmission of DR2 to diseased offspring from diseased parents (21 of 27) and to diseased offspring from healthy parents (15 of 17) in contrast to the transmission of DR2 from either group of parents to healthy offspring (six of 15 and 10 of 16, respectively). The segregation of non-HLA polymorphisms did not deviate significantly from the expected figures. These data provide strong evidence in favor of DR2-associated susceptibility to pulmonary tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415179     DOI: 10.1093/infdis/148.4.676

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

Review 1.  Science, medicine, and the future: susceptibility to infection.

Authors:  D Kwiatkowski
Journal:  BMJ       Date:  2000-10-28

2.  Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali.

Authors:  Amadou Kone; Bassirou Diarra; Keira Cohen; Seydou Diabate; Bourahima Kone; Mahamane T Diakite; Hawa Diarra; Moumine Sanogo; Antieme C G Togo; Yeya Dit Sadio Sarro; Bocar Baya; Nadie Coulibaly; Ousmane Kodio; Chad J Achenbach; Robert L Murphy; Jane L Holl; Sophia Siddiqui; Seydou Doumbia; William R Bishai; Souleymane Diallo; Mamoudou Maiga
Journal:  HLA       Date:  2019-01-02       Impact factor: 4.513

Review 3.  Key issues in the diagnosis and management of tuberculosis.

Authors:  Heather Milburn
Journal:  J R Soc Med       Date:  2007-03       Impact factor: 5.344

Review 4.  Genetics and pulmonary medicine. 3. Genetic susceptibility to tuberculosis in human populations.

Authors:  R Bellamy
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

5.  Repertoires of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis BCG.

Authors:  K Huygen; L Ljungqvist; R ten Berg; J P Van Vooren
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 6.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

7.  Deficient immune interferon production in tuberculosis.

Authors:  J K Onwubalili; G M Scott; J A Robinson
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

Review 8.  Epidemiological models of Mycobacterium tuberculosis complex infections.

Authors:  Cagri Ozcaglar; Amina Shabbeer; Scott L Vandenberg; Bülent Yener; Kristin P Bennett
Journal:  Math Biosci       Date:  2012-03-01       Impact factor: 2.144

9.  Personalized medicine approach in mycobacterial disease.

Authors:  Mehdi Mirsaeidi
Journal:  Int J Mycobacteriol       Date:  2012-06

10.  T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.

Authors:  P Launois; K Huygen; J De Bruyn; M N'Diaye; B Diouf; L Sarthouj; J Grimaud; J Millan
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.